Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

Cheap OEM Software
 

Search in our Online Store

Kurve Technology Signs Agreement With Schering-Plough Corporation Print E-mail
21 Mar 2006
Nasal Drug Delivery Firm Inks Deal With Global Health Care Company

BOTHELL, WA, USA | Mar 20, 2006 |
Kurve Technology, Inc., a leader in nasal drug delivery devices, today announced it has entered into an agreement with Schering-Plough Corporation.

"We are delighted to partner with a global pharmaceutical leader," said Marc Giroux, Chairman and Chief Executive Officer of Kurve Technology, Inc. "The value of our Controlled Particle Dispersion(TM) technology platform and ViaNase(TM) device line continues to grow and we are excited about working with the team at Schering-Plough."

Incorporating patented Controlled Particle Dispersion(TM) and intelligent nasal drug delivery technologies, Kurve Technology's ViaNase electronic atomizer intranasally delivers topical, systemic and nose-to-brain medical therapies with greater efficacy and efficiency than traditional nasal delivery devices such as spray pumps. ViaNase is the first nasal drug delivery device that saturates the entire nasal cavity, allowing potential delivery to the paranasal sinuses. In addition, ViaNase limits peripheral deposition of pharmaceutical formulations into the lungs or stomach. Kurve Technology most recent device offering -- ViaNase ID(TM) -- incorporates drug pedigree confirmation, lock-out technology, and an electronic display to curb counterfeit drug use and abuse while improving patient compliance.

About Kurve Technology, Inc.

Kurve Technology, Inc. offers pharmaceutical companies innovative nasal delivery systems for local and systemic medical therapies. Kurve's Controlled Particle Dispersion (CPD)(TM) technology intranasally delivers formulations with far greater efficacy and efficiency than traditional methods. The ViaNase product line of intelligent atomizers incorporates CPD to deliver a wide range of compounds, aiding the more than 200 million patients who suffer from such medical conditions as allergic rhinitis, chronic rhinosinusitis, sexual dysfunction, migraine headache, obesity, and CNS disease. Kurve Technology is headquartered in Bothell, WA with an office in Research Triangle Park, NC. For additional information, please visit http://www.kurvetech.com.

SOURCE: Kurve Technology, Inc




Digg!Reddit!Del.icio.us!Google!Live!Facebook!Slashdot!Netscape!Technorati!StumbleUpon!Spurl!Wists!Simpy!Newsvine!Blinklist!Furl!Fark!Blogmarks!Yahoo!Smarking!Netvouz!Shadows!RawSugar!Ma.gnolia!PlugIM!Squidoo!BlogMemes!FeedMeLinks!BlinkBits!Tailrank!linkaGoGo!Free social bookmarking plugins and extensions for Joomla! websites! title=
 

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Diabetes Drug Pipeline

Order Now

Brief Report Series

CD40 and CD40L (CD154) Agonists & Antagonists

Order Now

Subscribe La Merie Biologics